Updated on 20 October 2026
Key product Europe can own: hollow microneedle arrays
Founder & Chief Operating Officer at SmartForge
London, United Kingdom
About
Every injectable medicine in Europe passes through a supply chain that is concentrated and largely non-European: prefilled syringes, their glass barrels and their stainless steel needles. Hollow microneedle arrays replace all three with a single molded polymer part, and they are not made at commercial scale anywhere in the world. There is no incumbent to displace. The capability is unbuilt, and it will belong to the region that builds it first.
Hollow microneedles were a research goal for three decades and manufacturing was always the obstacle: 3M worked on laser-drilled arrays for more than fifteen years and never exceeded eighteen microneedles per patch. SmartForge molds the microneedles, their lumens and the base together in one shot. The arrays flow from every microneedle and penetrate skin models repeatedly without damage. Several top-20 pharmaceutical companies are in discussion with us.
Circularity is direct: one polymer part in place of glass and steel, no critical raw materials, and a regulated sharps waste stream removed from clinics and homes.
We are looking for a coordinator with a Made in Europe track record to build a MAT-PROD-02 consortium around this key product, with a tooling and micro-replication RTO, an in-line metrology partner, a machinery builder for the production cell, a digital-twin or simulation partner, and a pharmaceutical or CDMO end user. We bring the process, in-house tooling, demonstrator parts and the micro-molding work package. No geographic preference; widening-country partners welcome. PIC 860558587.
Stage
- Ideation - identifying the project idea
Topic
- CL4 | MAT-PROD-01: Advanced manufacturing for key products (IA) - MiE
Call
- Cluster 4 2027 Call - INDUSTRY
Type
- Partner seeks Consortium
Attached files
Organisation
Similar opportunities
Project cooperation
Micro-molding partner for your key product
- Completing the consortia
- Partner seeks Consortium
- Cluster 4 2027 Call - INDUSTRY
- CL4 | MAT-PROD-01: Advanced manufacturing for key products (IA) - MiE
Aron Rachamim
Founder & Chief Operating Officer at SmartForge
London, United Kingdom
Project cooperation
Manufacturing partner for a breakthrough micro-component, TRL 2 to 4
- Completing the consortia
- Partner seeks Consortium
- Cluster 4 2027 Call - INDUSTRY FTRI
- CL4-FTRI | MAT-PROD-61: Fast Track to Research and Innovation for breakthroughs in industrial technologies (RIA)
Aron Rachamim
Founder & Chief Operating Officer at SmartForge
London, United Kingdom
Expertise
Bio-based and biodegradable PCE flexibilizers for modification of bio-based polymers
- Circular technologies
- Advanced materials and chemicals
- Science and technology infrastructures
Szymon Roszyk
Junior Science Specialist at Poznan Science and Technology Park
Poznan, Poland